Sign In
Buy ABMD
$381.02
+0 (+0%)
At Close: Mar 20, 2023
3 Overlooked Healthcare Stocks to Buy Right Now
06:00am, Saturday, 10'th Apr 2021
The best is yet to come for each of these companies.
Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification
07:00am, Thursday, 08'th Apr 2021
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed announces that on Thursday, April 29, 2021 the Company will release financial results for the fourth quarter of fiscal 2021.
3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis
09:06am, Tuesday, 30'th Mar 2021
3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis
This Company Will Fix the Hidden COVID Danger to Come
07:37am, Sunday, 21'st Mar 2021
There are long-term implications to the coronavirus pandemic that the market is not appreciating.
CMD or ABMD: Which Is the Better Value Stock Right Now?
12:53pm, Thursday, 11'th Mar 2021
CMD vs. ABMD: Which Stock Is the Better Value Option?
Could Abiomed Be a Millionaire-Maker Stock?
06:00am, Wednesday, 10'th Mar 2021
This medical device company has revenue growth, patents, and a bright outlook.
Abiomed (ABMD) Down 8.6% Since Last Earnings Report: Can It Rebound?
12:11pm, Saturday, 27'th Feb 2021
Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock?
Why You Should Retain Abiomed (ABMD) Stock in Your Portfolio
12:51pm, Thursday, 11'th Feb 2021
Investor confidence is high in Abiomed (ABMD) stock, courtesy of its solid prospects.
Here's the Surprising Coronavirus Stock You'll Really Want to Own
06:20am, Tuesday, 02'nd Feb 2021
It's not a vaccine company, a drugmaker, or a diagnostics company.
Abiomed (ABMD) Posts Upbeat Impella SmartAssist Study Results
11:22am, Monday, 01'st Feb 2021
The study proves that Abiomed's (ABMD) Impella 5.5 with SmartAssist delivers successful clinical and device outcomes.
Large Clinical Study Presented at STS 2021 Finds 79% Survival Rate with Impella 5.5 with SmartAssist
09:03am, Friday, 29'th Jan 2021
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces a large study of 356 patients treated with Impella 5.5 with SmartAssist at 16 U.S. and German centers found a 79% survival rate at exp
Why Abiomed Stock Popped Today
01:51pm, Thursday, 28'th Jan 2021
The company released its latest quarterly report.
Abiomed, Inc.'s (ABMD) CEO Michael Minogue on Q3 2021 Results - Earnings Call Transcript
01:08pm, Thursday, 28'th Jan 2021
Abiomed, Inc.'s (ABMD) CEO Michael Minogue on Q3 2021 Results - Earnings Call Transcript
Abiomed (ABMD) Q3 Earnings and Revenues Beat Estimates
09:47am, Thursday, 28'th Jan 2021
Abiomed (ABMD) delivered earnings and revenue surprises of 1.74% and 2.81%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
